<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000523326"><TermName>NCX 4016</TermName><TermDefinition><DefinitionText>A substance being studied in the prevention of colorectal cancer. It is a form of aspirin that gives off nitric oxide gas and is less irritating to the lining of the stomach than plain aspirin. It is a type of nonsteroidal anti-inflammatory drug (NSAID). Also called nitric oxide-releasing acetylsalicylic acid derivative.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>NCX 4016</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para la prevención de cáncer colorrectal. Es una forma de aspirina que libera gas de ácido nítrico y es menos irritante para el revestimiento del estómago que la aspirina simple. Es un tipo de medicamento antiinflamatorio no esteroideo (AINE). También se llama derivado del ácido acetilsalicílico liberador de óxido nítrico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-12-01</DateFirstPublished></GlossaryTerm>
